SCOTUS 2027 Term: Birthright Citizenship, Mifepristone, Trans Rights
ANALYSIS — 2027

SCOTUS 2027 Term: Birthright Citizenship, Mifepristone, Trans Rights

What the Supreme Court will decide in its 2026-2027 term: birthright citizenship challenge, mifepristone access, trans rights cases, and how polling lines up with the justices.

62%
Support birthright citizenship
60%
Mifepristone share of all US abortions
58%
Support anti-discrimination protections for trans people
6-3
Conservative majority, appointed by R presidents
Key Findings
  • The 2026–2027 SCOTUS term will arrive after the November 2026 election, but the cases accepted or granted certiorari before the election shape campaign arguments about the court's direction.
  • The court's docket reflects the executive power agenda of the Trump second term: cases involving emergency spending authority, agency independence, and the scope of presidential regulatory power are the defining cluster.
  • Three cases from the 2025–2026 term set major precedents that will be interpreted and litigated in the 2026–2027 cycle — courts rarely issue clean final rulings; each major decision spawns follow-on cases.
  • The birthright citizenship challenge, if not resolved in 2025–2026, carries into 2026–2027 as a continuing constitutional question affecting immigration enforcement and congressional representation calculations.
  • For 2026 candidates, the 2026–2027 docket provides forward-looking arguments: Democrats can run on "what comes next" from a court that has shown a consistent direction, while Republicans defend that direction as legally correct.

Key Cases: 2026–2027 SCOTUS Term

Case / Issue Status Issue Public Opinion
Birthright Citizenship Challenge On Docket Executive order limiting 14th Amendment scope vs. Wong Kim Ark precedent 62% pro-birthright
Mifepristone State Preemption Likely 2027 Can states ban FDA-approved drugs? Federal preemption clause 64% oppose state bans
Trans Youth Healthcare On Docket States banning gender-affirming care for minors; post-Skrmetti scope 52% oppose bans
Voting Rights Act Section 2 Possible 2027 Racial gerrymandering and minority representation standards 61% support VRA protections
NLRB Authority Scope On Docket Labor board power after Loper Bright's Chevron overrule 59% support worker protections
First Amendment & Social Media Possible 2027 State laws compelling platforms to host speech; Murthy v. Missouri sequel 54% oppose government content mandates
SCOTUS 2027 Term: Birthright Citizenship, Mifepristone, Trans Rights

The Three Defining Cases

Birthright Citizenship

14th Amendment Test

The Trump executive order signed in January 2025 challenged the birthright citizenship interpretation that has governed since the 1898 Wong Kim Ark case. Lower courts blocked it universally. The Supreme Court must decide both the constitutional question and whether nationwide injunctions by single district courts are permissible. The latter question may be the Court's actual focus — a limiting ruling that doesn't resolve the constitutional substance.

Mifepristone Access

Federal vs. State Authority

With mifepristone accounting for 63% of US abortions as of 2025, any SCOTUS polling restricting its availability would have a larger real-world impact than the Dobbs decision. The legal theory being developed by challengers: that FDA approval of abortion drugs does not preempt state bans, and states can enforce restrictions on federally-approved medications. This is an aggressive and historically unprecedented preemption theory.

Trans Rights

Post-Skrmetti Landscape

The 2025 Skrmetti ruling upheld Tennessee's ban on gender-affirming care for minors, with the majority finding no sex discrimination under the Equal Protection Clause. The 2027 term will likely address adult care bans, insurance coverage requirements, and whether Title IX protections extend to trans students. Each case will draw intense public attention and fuel fundraising on both sides for the 2028 cycle.

Court vs. Public: The Opinion Gap

A 6-3 Court in a 55-45 Nation

The current Supreme Court's 6-3 conservative majority was appointed by presidents who won a minority of popular votes in two elections. Gallup's SCOTUS polling rating has fallen to 43% — a modern low. This legitimacy gap has real political consequences: it energizes Democratic base voters, drives fundraising, and makes Court appointments a top-tier presidential voting issue, second only to the economy.

For 2026, the SCOTUS issue operates primarily as a motivator for Democratic turnout. Polling shows 68% of Democrats say Court appointments are "very important" to their vote, compared to 58% of Republicans who say the same. This asymmetry has contributed to the Democratic generic ballot lead in 2026 cycle polling.

LIVE
Generic Ballot Democrats48.1% Republicans41.1% D+7 Trump Approval Approve39% Disapprove58% Senate D47 R53 House D213 R222 Generic Ballot Tracker Trump Approval Senate 2026 House 2026 Latest Analysis